News
A new Dev Update has arrived, teasing long-awaited changes like a Replay System, another map, anti-smurfing measures and more. Let's explore a quick recap of what players can expect.
Preclinical data on AbCellera’s PSMA x CD3 T-cell engagers demonstrate potent anti-tumor activity and potential to further enhance function through costimulatory strategies ...
A nasal spray, referred to as nasal anti-CD3, could be the first FDA-approved treatment for traumatic brain injury, or TBI, that can be easily administered with no serious side effects, the ...
Novartis has finally given up on iscalimab after deciding that the anti-CD40 antibody is not worth pursuing in Sjögren’s syndrome.
Research showed that healthy infants mount a robust IgG response to the same epitope. “Anti-flagellin reactivity has been discovered and used in the clinic for Crohn’s diagnosis for more than two ...
NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its ...
The Board of Appeal confirmed that epitope claiming, in particular conformational epitope claiming, is valid, provided the patent contains sufficient information on antibody generation.
Antibody drug discovery is an extremely laborious and tedious process. Epitope Binning-seq, a novel method, introduces a groundbreaking approach by enabling simultaneous analysis of multiple ...
Vaccine development aims at protecting as many people as possible from infections. Short protein fragments of pathogens, so-called epitopes, are seen as a promising new approach for vaccine ...
Study design In this study, mice were treated three times a week with intranasal anti-CD3 for five months and compared against isotype control or saline. In the treated mice, the study found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results